Our colleagues at the Imaging Performance Partnership recently posted an article summarizing the results of a Journal of Medical Screening review of European studies on service screening for breast cancer.
Researchers uncovered a significant mortality benefit from screening, upending skeptical studies and reports published over the past few months.
In case you didn’t see the article, we've reposted it below.
In case you missed it: European breast cancer study finds substantial screening benefits
Megan Bailey, Oncology Roundtable
The rate of women in their 40s receiving mammograms has decreased by 5% since a 2009 recommendation issued by the U.S. Preventive Services Taskforce (USPSTF) against routine screening for women in this age group.
Mammogram rate has decreased since change in USPSTF recommendations
I was going to write a lengthy post on this, but the Daily Briefing beat me to it, so I've copied their piece below. I can't say I'm surprised by the recommendation, and hopefully this will reduce some of the confusion out there amongst both clinicians and consumers:
Rather than wait until age 50 to have an annual mammogram--as one task force controversially recommended in November--two groups now say that women should begin breast cancer screening at age 40, with high-risk patients starting even earlier.
In an article published online in the Journal of the American College of Radiology (JACR), the Society of Breast Imaging (SBI) and the American College of Radiology (ACR) recommend that women at average risk should begin annual breast cancer screening at age 40, while high-risk patients--those who carry the BRCA1 or BRCA2 mutation or who are untested first-degree relatives of a BRCA mutation carrier--should begin screening by age 30 but not before age 25.
New Recommendations Back Mammograms Starting at Age 40